000305423 001__ 305423
000305423 005__ 20251020115507.0
000305423 0247_ $$2doi$$a10.3390/cancers17193181
000305423 0247_ $$2pmid$$apmid:41097806
000305423 037__ $$aDKFZ-2025-02152
000305423 041__ $$aEnglish
000305423 082__ $$a610
000305423 1001_ $$00000-0001-9878-5106$$aLan, Bin$$b0
000305423 245__ $$aCorrection: Lan et al. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer. Cancers 2022, 14, 326.
000305423 260__ $$aBasel$$bMDPI$$c2025
000305423 3367_ $$2DRIVER$$aarticle
000305423 3367_ $$2DataCite$$aOutput Types/Journal article
000305423 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1760947556_1189494$$xErratum/Correction
000305423 3367_ $$2BibTeX$$aARTICLE
000305423 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000305423 3367_ $$00$$2EndNote$$aJournal Article
000305423 520__ $$aError in FigureIn the original publication [1], there was a mistake in Figure 2C right as published. An error occurred during figure assembly duplicating part of the figure. The corrected Figure 2C right appears below.Cancers 17 03181 g002Figure 2. DYRK1A knockout enhances radiotherapy efficacy in pancreatic cancer. (A) Western blot of TB32047 and MIA PaCa-2 cells transfected with DYRK1A sgRANs or non-targeting control. (B) A clonogenic assay of TB32047 (left) and MIA PaCa-2 (right) cells with DYRK1A KO and control sgRNA cells was performed after irradiation with different doses of X-rays. The colony numbers were counted and normalized. Data are presented as means of three independent experiments (n = 3). *, p < 0.05; **, p < 0.01; *** and p < 0.001 by 2-tailed unpaired Student’s t test. (C) TB32047 (left) and MIA PaCa-2 (right) single clones and control cells were treated with different doses of radiation followed by clonogenic assays. Representative images of three independent experiments (n = 3) are shown. (D,E) Flow cytometry-based apoptosis analysis of TB32047 (D) and MIA PaCa-2 (E) control and DYRK1A KO single clones irradiated with 5 Gy X-rays after 24 h. Representative images of three independent experiments (n = 3) and statistical analysis are shown. **, p < 0.01; ***, p < 0.001 and ****, p < 0.0001 by 2-tailed unpaired Student’s t test. ns. not significant.The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
000305423 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000305423 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000305423 7001_ $$00009-0007-5623-5457$$aZeng, Siyuan$$b1
000305423 7001_ $$aZhang, Shuman$$b2
000305423 7001_ $$aRen, Xiaofan$$b3
000305423 7001_ $$00000-0003-1583-9303$$aXing, Yuming$$b4
000305423 7001_ $$aKutschick, Isabella$$b5
000305423 7001_ $$aPfeffer, Susanne$$b6
000305423 7001_ $$00000-0001-6743-3351$$aFrey, Benjamin$$b7
000305423 7001_ $$00000-0002-0494-7117$$aBritzen-Laurent, Nathalie$$b8
000305423 7001_ $$aGrützmann, Robert$$b9
000305423 7001_ $$00000-0001-5684-629X$$aCordes, Nils$$b10
000305423 7001_ $$00000-0002-7968-3283$$aPilarsky, Christian$$b11
000305423 773__ $$0PERI:(DE-600)2527080-1$$a10.3390/cancers17193181$$gVol. 17, no. 19, p. 3181 -$$n19$$p3181$$tCancers$$v17$$x2072-6694$$y2025
000305423 909CO $$ooai:inrepo02.dkfz.de:305423$$pVDB
000305423 9101_ $$0I:(DE-588b)2036810-0$$60000-0001-5684-629X$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000305423 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000305423 9141_ $$y2025
000305423 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCERS : 2022$$d2024-12-14
000305423 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-14
000305423 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-14
000305423 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-14
000305423 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-14
000305423 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-14
000305423 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-14
000305423 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-14
000305423 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-14
000305423 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-14
000305423 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-14
000305423 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCERS : 2022$$d2024-12-14
000305423 9201_ $$0I:(DE-He78)DD01-20160331$$kDD01$$lDKTK Koordinierungsstelle Dresden$$x0
000305423 980__ $$ajournal
000305423 980__ $$aVDB
000305423 980__ $$aI:(DE-He78)DD01-20160331
000305423 980__ $$aUNRESTRICTED